Related references
Note: Only part of the references are listed.p53 Requires an Intact C-Terminal Domain for DNA Binding and Transactivation
Hyunjung Kim et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
The role of mutant p53 in human cancer
Amanda M. Goh et al.
JOURNAL OF PATHOLOGY (2011)
Gain of function of mutant p53 by coaggregation with multiple tumor suppressors
Jie Xu et al.
NATURE CHEMICAL BIOLOGY (2011)
p53 mutant breast cancer patients expressing p53 gamma have as good a prognosis as wild-type p53 breast cancer patients
Jean-Christophe Bourdon et al.
BREAST CANCER RESEARCH (2011)
Pharmacological reactivation of mutant p53: from protein structure to the cancer patient
K. G. Wiman
ONCOGENE (2010)
Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions
D. Walerych et al.
ONCOGENE (2009)
p53 Amino-Terminus Region (1-125) Stabilizes and Restores Heat Denatured p53 Wild Phenotype
Anuj Kumar Sharma et al.
PLOS ONE (2009)
Three Assays Show Differences in Binding of Wild-Type and Mutant p53 to Unique Gene Sequences
Uma Chandrachud et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2009)
Structural biology of the tumor suppressor p53
Andreas C. Joerger et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
Sanjeev Shangary et al.
Annual Review of Pharmacology and Toxicology (2008)
The genetics of the p53 pathway, apoptosis and cancer therapy
Alexei Vazquez et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
CHIP chaperones wild type p53 tumor suppressor protein
Veenu Tripathi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Detection and characterization of tumor hypoxia using pO2 histography
Peter Vaupel et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
p53 therapy in a patient with Li-Fraumeni syndrome
Neil Senzer et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Hypoxia induces p53-dependent transactivation and Fas/CD95-dependent apoptosis
T. Liu et al.
CELL DEATH AND DIFFERENTIATION (2007)
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura et al.
NATURE (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
Modeling the therapeutic efficacy of p53 restoration in tumors
Carla P. Martins et al.
CELL (2006)
The DU145 human prostate carcinoma cell line harbors a temperature-sensitive allele of p53
Marcio C. Bajgelman et al.
PROSTATE (2006)
Hypoxia and HIF-1α protect A549 cells from drug-induced apoptosis
S. E. Schnitzer et al.
CELL DEATH AND DIFFERENTIATION (2006)
p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment
Y Pan et al.
ONCOGENE (2004)
The use of transient chromatin Immunoprecipitation assays to test models for E2F1-specific transcriptional activation
JL Lavrrar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Hypoxia attenuates the p53 response to cellular damage
M Achison et al.
ONCOGENE (2003)
p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma
ER Sauter et al.
CANCER GENE THERAPY (2002)
Disassembly of transcriptional regulatory complexes by molecular chaperones
BC Freeman et al.
SCIENCE (2002)
The 'wildtype' conformation of p53: epitope mapping using hybrid proteins
PL Wang et al.
ONCOGENE (2001)
Regulation of p53 by hypoxia: Dissociation of transcriptional repression and apoptosis from p53-dependent transactivation
C Koumenis et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Stress signals utilize multiple pathways to stabilize p53
M Ashcroft et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)